CLOFAZIMINE FOR THE TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS: MULTICENTER, RANDOMIZED CONTROLLED STUDY

被引：0
|
作者：
Tang, Shenjie [1 ]
Hao, Xiaohui [1 ]
Yao, Lan [1 ]
Liu, Yidian [1 ]
Sun, Hua [1 ]
Gu, Jin [1 ]
机构：
[1] Tongji Univ, TB Diag & Treatment Ctr, Shanghai Pulm Hosp, TB Key Lab Shanghai, Shenyang, Peoples R China
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [1] Clofazimine For The Treatment Of Multidrug-Resistant Tuberculosis: Multicenter, Randomized Controlled Study
    Tang, S.
    Hao, X.
    Yao, L.
    Liu, Y.
    Sun, H.
    Gu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [2] Clofazimine For The Treatment Of Multidrug-Resistant Tuberculosis: Multicenter, Randomized Controlled Study
    Tang, S.
    Hao, X.
    Yao, L.
    Liu, Y.
    Sun, H.
    Gu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [3] Clofazimine for the treatment of multidrug-resistant tuberculosis: Multicenter, randomized controlled study
    Tang, Shenjie
    Hao, Xiaohui
    Yao, Lan
    Liu, Yidian
    Sun, Hua
    Gu, Jin
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [4] Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis: Prospective, Multicenter, Randomized Controlled Study in China
    Tang, Shenjie
    Yao, Lan
    Hao, Xiaohui
    Liu, Yidian
    Zeng, Linhai
    Liu, Gang
    Li, Mingwu
    Li, Fujian
    Wu, Meiying
    Zhu, Yousheng
    Sun, Hua
    Gu, Jin
    Wang, Xiafang
    Zhang, Zhanjun
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (09) : 1361 - 1367
  • [5] Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
    Tang, Shenjie
    Yao, Lan
    Hao, Xiaohui
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] Clofazimine for the treatment of multidrug-resistant tuberculosis
    Lange, C.
    Chesov, D.
    Heyckendorf, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (02) : 128 - 130
  • [7] Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
    Nugraha, Rhea Veda
    Yunivita, Vycke
    Santoso, Prayudi
    Aarnoutse, Rob E.
    Ruslami, Rovina
    SCIENTIA PHARMACEUTICA, 2021, 89 (02)
  • [8] Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial
    Duan, H.
    Chen, X.
    Li, Z.
    Pang, Y.
    Jing, W.
    Liu, P.
    Wu, T.
    Cai, C.
    Shi, J.
    Qin, Z.
    Yin, H.
    Qiu, C.
    Li, C.
    Xia, Y.
    Chen, W.
    Ye, Z.
    Li, Z.
    Chen, G.
    Wang, S.
    Liu, Y.
    Chu, L.
    Zhu, M.
    Xu, T.
    Wang, Q.
    Wang, J.
    Du, Y.
    Wang, J.
    Chu, N.
    Xu, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (02) : 190 - 195
  • [9] Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis
    Liu, Yuhong
    Gao, Jingtao
    Du, Jian
    Shu, Wei
    Wang, Lu
    Wang, Yufeng
    Xue, Zhongtan
    Li, Liang
    Xu, Shaofa
    Pang, Yu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 : 392 - 396
  • [10] Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China
    Du, Yadong
    Qiu, Chao
    Chen, Xiaohong
    Wang, Jing
    Jing, Wei
    Pan, Hongqiu
    Chen, Wei
    Liu, Yufeng
    Li, Chunxiang
    Xi, Xiu'e
    Yin, Hongyun
    Zeng, Jianfeng
    Zhang, Xia
    Xu, Tao
    Wang, Qingfeng
    Guo, Ru
    Wang, Jun
    Pang, Yu
    Chu, Naihui
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 1047 - 1054
12345